The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical foam market reached a value of US$ 26.98 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 40.31 Billion by 2027, exhibiting a CAGR of 6.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Medical foam refers to an antimicrobial product used in numerous medical devices, components, and support materials, such as surgical drapes, wound dressing, and bedding materials in the healthcare industry. It is manufactured using cell polyurethane, polymers and metals. Medical foam is also widely used in prosthetic padding, custom orthotics, sealing ostomy equipment and body underfoot pressure relief equipment. It exhibits various properties, such as water, strain and fungal resistance, softness, durability, sterility, and versatility, thus making it suitable for protective packaging purposes. Medical foams offer compression relieving capabilities that adapt to the patient’s body shape and assist in providing comfort, relaxation and alleviating pressure relief points. Currently, it is available in rigid, flexible, and molded product types.
The rising geriatric population across the globe that are more prone to developing various chronic ailments represents one of the key factors driving the growth of the market. Medical foam plays a vital role during patient recovery post major surgeries as they are widely used in bedding and cushioning products to enhance comfort. Additionally, the increasing usage of medical foam in numerous applications, such as medical system cushioning and wound dressings, due to its various properties, such as excellent compression-set resistance, impact-absorbing and versatility, is favoring the market growth. Apart from this, increasing cases of epidemic outbreaks, such as coronavirus disease (COVID-19) and swine flu, along with rising health concerns among people related to personal hygiene, are providing an impetus to the market growth. Moreover, the increasing demand for heat and moisture exchange (HME) foams in medical breathing and anesthesia systems and equipment that provide a consistent and controlled oxygen and gas intake, while also ensuring sterile conditions are positively impacting the market growth. Other factors, including the significant expansion in the medical industry, increasing demand for implantable medical devices, and the shifting inclination from traditional to advanced wound care products are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical foam market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, material and application.
Breakup by Type:
Breakup by Material:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Medical Solutions Group Plc, BASF SE, Draka Interfoam B.V., Foamtec Medical, Freudenberg Performance Materials, FXI, General Plastics Manufacturing Company Inc., Global Medical Foam Inc., Inoac Corporation, Recticel NV, Rogers Corporation, SEKISUI CHEMICAL CO. LTD. and Ufp Technologies Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Material, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Advanced Medical Solutions Group Plc, BASF SE, Draka Interfoam B.V., Foamtec Medical, Freudenberg Performance Materials, FXI, General Plastics Manufacturing Company Inc., Global Medical Foam Inc., Inoac Corporation, Recticel NV, Rogers Corporation, SEKISUI CHEMICAL CO. LTD. and Ufp Technologies Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at